Financial Statements Year End December 31, 2010 (6058M)
August 18 2011 - 5:49AM
UK Regulatory
TIDM53HZ
RNS Number : 6058M
Kazanorgsintez S.A.
18 August 2011
Director's Report The directors present their annual report and
the financial statements for the year ended December 31, 2010.
1. ACTIVITIES AND REVIEW OF THE DEVELOPMENT OF THE BUSINESS
The object of the Company is the granting of loans or other
forms of financing directly or indirectly in whatever means to
Kazan Open Joint Stock Company <<Organichesky sintez>>
(e.g. including, but not limited to, by subscription of bonds,
debentures, other debt instruments, advances, the granting of
pledges or the issuing of other guarantees of any kind to secure
the obligations of Kazan Open Joint Stock Company
<<Organichesky sintez>>).
The Company may finance itself in whatever form including,
without being limited to, through borrowing or through issuance of
listed or unlisted notes and other debt instruments (e.g. including
but not limited to bonds, notes, loan participation notes and
subordinated notes) including under stand alone issues, medium term
note and commercial paper programmes.
The Company may also:
- grant security for funds raised, including notes and other
debt instruments issued, and for the obligations of the Company;
and
- enter into all necessary agreements, including, but not
limited to underwriting agreements, marketing agreements,
management agreements, advisory agreements, administration
agreements and other contracts for services, selling agreements,
deposit agreements, fiduciary agreements, hedging agreements,
interest and/or currency exchange agreements and other financial
derivative agreements, bank and cash administration agreements,
liquidity facility agreements, credit insurance agreements and any
agreements creating any kind of security interest.
In addition to the foregoing, the Company can perform all legal,
commercial, technical and financial investments or operation and in
general, all transactions which are necessary or useful to fulfill
its objects as well as all operations connected directly or
indirectly to facilitating the accomplishment of its purpose in all
areas described above, it being understood that the Company will
not enter into any transaction which would cause it to be engaged
in any activity that would be a regulated activity of the financial
sector.
On the October 26, 2006 the Company has issued Loan
participation notes in amount of USD 200,000,000 which proceeds has
been used to grant the Loan to Kazan OJSC.
In April 2009 an Event of Default has occured under Clause 15.3
of the Loan Agreement due to the failure of Kazan JSC "Organichesky
sintez" (the Borrower) to make a payment of principal in respect of
its indebtedness on the April 2009 payment date. Following
deterioration of the business and financial conditions for the
Borrower's operations the Borrower has taken steps to postpone the
repayment of principal amounts and any accrued interest. This
restructurisation has been completed in February 2010 by inviting
Investors to offer to sell any or all of the Notes held by them and
to vote in favour of the Extraordinary Resolutions, as described in
the Tender and Consent Memorandum. The Eurobonds redemption was in
the amount of USD 89.259.000 and as a result the principal amount
that remains in circulation is in the amount of USD 100.834.000
since March 2010. The maturity of the Notes originally was March
19, 2011 and has been extended to March 19, 2015 which is the same
day as the repayment Date of the Loan.
The total expenses of EUR 9,065,743 are represented mainly by
interest payable and similar charges of EUR 9,020,066
The total income of EUR 9,065,743 are represented mainly by
other interest receivable and similar income of EUR 9,020,066
2. RESULTS AND ALLOCATION
The result for the year ended is nil.
3. POST BALANCE SHEET EVENTS
There were no important events since the year end which could
influence the presentation of the current financial statements.
4. PROPOSAL
We propose the approval of the annual financial statements as
well as the proposed allocation of the results and to give full
discharge to the board of directors and independent auditor for
their mandates during the year to December 31, 2010.
To see the full 2010 financial statements, please click on the
link below.
http://www.rns-pdf.londonstockexchange.com/rns/6058M_1-2011-8-18.pdf
This information is provided by RNS
The company news service from the London Stock Exchange
END
FR BGGDILXBBGBI
Santander 24 (LSE:53HZ)
Historical Stock Chart
From Feb 2025 to Mar 2025
Santander 24 (LSE:53HZ)
Historical Stock Chart
From Mar 2024 to Mar 2025